Packaging Design QuickFire Challenge: Unit Dose Technologies

作为产品的科学和创新进化，所以必须包装这些产品。前进的单位剂量包装的其他选择可以代表下一代药物储存。

在美国，由于对用户友好的访问和设计的担忧，因此受到不可闭合的单位剂量包装的更广泛采用[1], non-recyclable packaging waste, manufacturability and speed at which packaging lines can operate[2]。

In addition to helping to prevent accidental unsupervised ingestions (AUIs) of medications by children, some unit dose packaging configurations have also shown to increase medication adherence[3]，改善监测[4], and reduce risk of contamination[5]。While strides have been made in packaging safety[6], AUIs, when young children self-ingest medicines which are not appropriately kept high and out of sight and reach, can lead to overdose and preventable injury[7]。

To inspire innovators to bring potentially groundbreaking unit dose packaging options to the market – with a focus on child-resistant, user-friendly, non-reclosable designs - Johnson & Johnson Innovation together with the packaging innovation team within Johnson & Johnson Consumer Inc. is launching thePackaging Design QuickFire Challenge: Unit Dose Technologies.Potential innovations can include both solids (tablets, capsules and powders) and liquids (solutions and suspensions) in unit-dose formats (e.g. blisters, sachets and stick packs). Primary and secondary packaging or combination of the two are in scope of the challenge.

创新者具有最好的想法，潜在的技术或潜在解决方案，将获得高达10万美元的总池，获得全球Johnson＆Johnson Innovencation - Jlabs Network和Johnson＆Johnson家族专家的奖励乐动体育意甲直播公司。

*须遵守必要文件和（奖项）协议

Application Process

提交的提交将关注下面显示的“主要标准”。“也考虑的标准”将帮助您区分您的提交，申请人预计会详细阐述这些标准如何或不予解决。

Main criteria:

• 耐居民和用户友好的包装，涵盖F1通过F9 *的F1范围*
• Aim for unit-dose non-reclosable formats.
• 提供良好的用户体验。一些例子是：易于使用/开放，无挫折开放，可移植性，吸引力。
• 这个想法的新奇。

Criteria to also consider:

• 增加可持续性。
• Easily integrates into existing packaging lines with minimal modification
• 年代upport to patience adherence.
• Cost-effective, scalable & manufacturable
• Tamper evidence.
• 药物的障碍需求。
• 打开和摄取的安全性。（例如，由于包装的尖锐边缘，用户切割）

** Ideas are not expected to have a test certificate but should consider as a reference to the16CFR§1700.20。In general, a child resistant and user friendly test consists of two parts. For the first part, a child must not access to “F” amount of unit doses in a period of 10 minutes. F1 means test failure when a child accesses to 1 unit dose. F9 means failure when a child accesses to 9 unit doses. The second part of the test is the user friendly test. A user should be able to open the packaging in a period of 1 minute.

Why this challenge matters to us

在Johnson＆Johnson Innovation，我们相信一个好主意可以来自任何地方，我们的目标是找到创新的健康解决方案，旨在改善世界各地的健康。我们知道，尽管父母和护理人员在预防他们发生的意外无监督时最佳努力。在一起，我们可以激发一个可能会改变世界各地成人和儿童的健康轨迹的下一个好主意。

About Johnson & Johnson Innovation

Johnson & Johnson Innovation LLC works across the pharmaceutical, medical device and consumer health sectors to accelerate early-stage, transformational solutions by catalyzing the best ideas, wherever they are in the world. We do this by harnessing our deep scientific capabilities coupled with a wide range of tools, including customized deal structures, company creation, incubation and startup services, capital investments and other innovative business models that aim to meet the diverse needs of entrepreneurs, scientists and emerging companies. Our goal is to help life science and health technology innovations thrive through collaboration and partnership with the global ecosystem, so that together we can change the trajectory of human health. Meet our passionate team of science and technology experts and learn how to collaborate with us atwww.jnjinnovation.com。

关于Johnson＆Johnson Consumer Inc.

在强生消费者健康,我们开车n to improve the personal health of people everywhere. Our differentiated portfolio of iconic brands, including Tylenol®, Zarbee's®, Neutrogena®, Aveeno®, Listerine®, OGX®, and Johnson's®, delivers life-enhancing, first-to-market innovation. By combining the power of science with meaningful human insights and digital-first thinking, we help more than 1.2 billion people live healthier lives every day, from their very first day.